News

Bloomberg Law Publishes Ethan Krasnoo’s Article Analyzing Defamation and Covid-19 Transmission Accusations

As businesses begin to reopen, defamation-related questions await both employers and employees. Can a claim for defamation be successfully brought against an employee falsely claiming another employee has contracted Covid-19? How about if an employee falsely alleges that an employer did not take adequate measures to protect its employees from...

Read More

RPJ’s New York: Elizabeth Jennings

This is the latest in a series of non-legal articles on the city we work in and love. On a hot New York City Sunday in July 1854, a 24-year-old African-American woman named Elizabeth Jennings was trying to get to church. She boarded a horse-drawn streetcar at the corner of...

Read More

The Chronicle of Higher Education Features Mark H. Moore in Article on Colleges’ Liability Amidst COVID-19

As colleges and universities across the country make decisions about whether to return to in-person classes in the fall, and what that will look like, they face numerous obstacles and liability concerns. The Chronicle of Higher Education published an article on May 29 illuminating the many issues, featuring quotes and...

Read More

Alice Jump Discusses Retail Grower Relationships Post-COVID-19 with American Vegetable Grower Magazine

COVID-19 has introduced tensions into the contractual relationship between vegetable growers and grocery retailers. Despite being open, many grocery stores tried to limit produce stock because they didn’t have enough, or consistent, labor to unload and process. That meant growers had to discard large percentages of their harvest and incur...

Read More

Nafsika Karavida Discusses U.S. and EU Approaches to Vaccine Patents and Compulsory Licensing Amid COVID-19

Governments, pharmaceutical companies and medical researchers around the world are racing to produce a vaccine for COVID-19, as well as potential drugs to fight the virus in those who contract it. The numbers show at least 70 reported potential vaccines and 150 other drugs for treatment that are in development...

Read More